´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 2ÀÏÂ÷ : 2024-06-14 |
|
´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 2ÀÏÂ÷ : 2024-06-14 ±³À°ÁÖÁ¦ : APCN & KSN 2024 2ÀÏÂ÷ ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ À̸ÞÀÏ : ksn@ksn.or.kr ±³À°Á¾·ù : ³»°ú Âü¼®¿¹»óÀÎ : 2000¸í Áö¿ª : ¼¿ïƯº°½Ã ¼¼ºÎ¼ö°·á : 250,000¿ø ºñ°í ¡áȸ¿ø: »çÀü(200,000)/ÇöÀå(250,000) ¡áºñȸ¿ø: »çÀü(250,000)/ ÇöÀå(250,000) ¡áPhysician in training/Nurse/Paramedics/Allied Health: »çÀü(100,000)/ ÇöÀå(125,000) *Student, ¸¸65¼¼ ÀÌ»ó ȸ¿ø: ¸éÁ¦
±³À°½Ã°£ 06¿ù 14ÀÏ Room 1 08:30~08:50 Volume Measurement and Management in AKI ¾ÈÁ¤³²(ÇѸ²´ëÇб³ ¼º½Éº´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 1 08:50~09:10 Management of Sepsis Associated AKI Kent Doi(The University of Tokyo Graduate School of Medicine) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 1 09:10~09:30 Progression from AKD or AKI to CKD: Mechanisms and Clinical Implications Vin-Cent Wu(National Taiwan University Hospital) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 1 09:30~09:50 Post-AKI Survivors Care: Who, When and How? Nattachai Srisawat(Chulalongkorn University) Åä·Ð 06¿ù 14ÀÏ Room 1 09:50~10:00 Q&A All Speaker() ÈÞ½Ä 06¿ù 14ÀÏ 10:00~10:30 Break () ±³À°½Ã°£ 06¿ù 14ÀÏ Room 1 10:30~10:50 KSN Recommendations for CRRT Management ±è¼¼Áß(ºÐ´ç¼¿ï´ëÇб³º´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 1 10:50~11:10 Updates on Current Ongoing Clinical Trials in CRRT Kathleen Liu(University of California San Francisco) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 1 11:10~11:30 Citrate Anticoagulation in Crrt: How to Monitor? Marlies Ostermann(King) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 1 11:30~11:50 How to Run CRRT in ECMO Patients? Manish Kaushik(Singapore General Hospital) Åä·Ð 06¿ù 14ÀÏ Room 1 11:50~12:00 Q&A All Speaker() Åä·Ð 06¿ù 14ÀÏ Room 1 15:00~16:30 Oral Communications 4: Dialysis 2 ±Ç¼ø±æ, Vuddhidej Ophascharoensuk(ÃæºÏ´ëÇб³º´¿ø, Chiang Mai University Thailand) ÈÞ½Ä 06¿ù 14ÀÏ 16:30~17:00 Break () ±³À°½Ã°£ 06¿ù 14ÀÏ Room 1 17:00~17:20 Debate on Treatment for IgA Nephropathy Jicheng Lv(Peking University First Hospital) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 1 17:20~17:40 Update in Management of ANCA-Associated Vasculitis David R.W. Jayne(Cambridge University Hospitals) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 1 17:40~18:00 Current and Future Prospects for Management of Membranous Nephropathy Daniel C Cattran(University of Toronto) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 1 18:00~18:20 Avoiding Steroid in Treatment of Minimal Change Disease ±è¿ëö(¼¿ï´ëÇб³º´¿ø) Åä·Ð 06¿ù 14ÀÏ Room 1 18:20~18:30 Q&A All Speaker() ±³À°½Ã°£ 06¿ù 14ÀÏ Room 2 08:30~08:50 Integrating Telemedicine in Green Nephrology: Building a Sustainable Big Data and AI Ecosystem for Intelligent Kidney Care Joseph Chin-Chi Kuo(China Medical University) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 2 08:50~09:10 Residential Green and Kidney Diseases: Epidemiological Evidence ÀÌȯÈñ(ºÎ»ê´ëÇб³) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 2 09:10~09:30 Air Pollution and Kidney Disease: Mechanisms Proposed for the Effect of Particulate Matter on Renal Health °´öÈñ(À̴뼿ﺴ¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 2 09:30~09:50 Green Nephrology Shaundeep Sen(Concord Repatriation General Hospital) Åä·Ð 06¿ù 14ÀÏ Room 2 09:50~10:00 Q&A All Speaker() ÈÞ½Ä 06¿ù 14ÀÏ 10:00~10:30 Break () ±³À°½Ã°£ 06¿ù 14ÀÏ Room 2 10:30~10:50 Advantages of PD Over HD: Patient-reported Outcomes Á¶¿µÁö(Princess Alexandra Hospital) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 2 10:50~11:10 Advantages of PD Over HD: Clinical Outcomes ÀÓÁ¤ÈÆ(Ä¥°î°æºÏ´ëÇб³º´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 2 11:10~11:30 Outcomes of EPS: What Can Be Done? Sunita Bavanandan(Hospital Kuala Lumpur) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 2 11:30~11:50 How to Achieve Improvement of PD Penetration? Talerngsak Kanjanabuch(King Chulalongkorn Memorial Hospital) Åä·Ð 06¿ù 14ÀÏ Room 2 11:50~12:00 Q&A All Speaker() ±³À°½Ã°£ 06¿ù 14ÀÏ Room 3 08:30~08:50 Understanding the Mechanism of Interstitial Fibrosis in the Kidney Yasunori Iwata(Kanazawa University) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 3 08:50~09:10 Unraveling the Role of YAP/TAZ Signaling in Kidney Fibrosis ÃÖ½ÂÇõ(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 3 09:10~09:30 Gut Dysbiosis and CKD Á¶»ó°æ(°í·Á´ëÇб³ ¾È¾Ïº´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 3 09:30~09:50 Therapeutic Strategies for Managing Kidney Fibrosis Katsuhiko Asanuma(Chiba University Graduate School of Medicine) Åä·Ð 06¿ù 14ÀÏ Room 3 09:50~10:00 Q&A All Speaker() ÈÞ½Ä 06¿ù 14ÀÏ 10:00~10:30 Break () ±³À°½Ã°£ 06¿ù 14ÀÏ Room 3 10:30~10:50 GWAS Studies in Chronic Diseases °û¼öÇå(¼¿ï´ëÇб³º´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 3 10:50~11:10 Proteomics in CKD Eugene Rhee(Massachusetts General Hospital) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 3 11:10~11:30 Stem Cells and Chronic Kidney Disease Cai-Mei Zheng(Taipei Medical University Shuang-Ho Hospital) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 3 11:30~11:50 Tertiary Lymphoid Tissues: A Novel Kidney Inflammation Marker and Therapeutic Target Motoko Yanagita(Kyoto University) Åä·Ð 06¿ù 14ÀÏ Room 3 11:50~12:00 Q&A All Speaker() Åä·Ð 06¿ù 14ÀÏ Room 3 15:00~16:30 Oral Communications 5: Glomerulonephritis Jicheng Lv , ¿À¼¼¿ø(°í·Á´ëÇб³ ¾È¾Ïº´¿ø, Peking University First Hospital) ÈÞ½Ä 06¿ù 14ÀÏ 16:30~17:00 Break () ±³À°½Ã°£ 06¿ù 14ÀÏ Room 3 17:00~17:20 State-of-art Treatment for DKD Katherine R. Tuttle(University of Washington) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 3 17:20~17:40 New Pathogenesis of DKD: Mechanosensitive Injury Signaling Tobias B. Huber(University Medical Center Hamburg-Eppendorf) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 3 17:40~18:00 Novel Next-Generation Drugs for DKD in the Pipeline David Z. I. Cherney(Toronto General Hospital Research Institute) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 3 18:00~18:20 New Biomarker for DKD: Urinary EV ÃÖµ¿½Ä(¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ) Åä·Ð 06¿ù 14ÀÏ Room 3 18:20~18:30 Q&A All Speaker() ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 08:30~08:37 Gait Of CKD Patients ±èÇö¼÷(ÇѸ²´ëÇб³ Ãáõ¼º½Éº´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 08:37~08:44 Elucidation of Podocyte Apoptosis Mechanisms in Diabetic Nephropathy Using Multi-omics Approaches ¹®ÁÖ¿µ(°µ¿°æÈñ´ëÇб³º´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 08:44~08:51 Vitamin D as a Molecular Treatment Candidate to Prevent Vascular Access Stenosis in Hemodialysis Patients ·ùÁ¤È(À̴뼿ﺴ¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 08:51~08:58 Modeling of Endothelial Cell Dysfunction Using Patient-derived Induced Pluripotent Stem Cells ÀÌÇѺñ(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 08:58~09:05 Identification of DICAM ÀÓÁ¤ÈÆ(Ä¥°î°æºÏ´ëÇб³º´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 09:05~09:12 Standards for Facilities and Operations For Infection Control in Hemodialysis Units in Korea Ȳ¿ø¹Î(°Ç¾ç´ëÇб³º´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 09:12~09:19 Expression of Lysyl Oxidase Related Protein and Effect of Lysyl Oxidase Inhibition in Cyclosporine Induced Nephropathy Mouse Model ±èÈ¿Á¤(°³²¼¼ºê¶õ½ºº´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 09:19~09:26 Role of B Cell Metabolism in Ischemic Acute Kidney Injury Repair ÀÌ°æÈ£(»ï¼º¼¿ïº´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 09:26~09:33 Improvement of Blood Glucose Levels and Variability Using Continuous Glucose Monitoring in Chronic Kidney Disease with Diabetes À̼ö¾Æ(´ëÀüÀ»Áö´ëÇб³º´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 09:33~09:40 The Effect of HNF4A on Podocytes Á¤¼ö¿õ(°µ¿°æÈñ´ëÇб³º´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 09:40~09:47 Single Cell Transcriptomics in Childhood Onset Lupus Nephriti ±è¼ºÇå(¼¿ï´ëÇб³º´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 09:47~09:54 Necrox-7 Improves Kidney Tissue Damage Caused by Fibrosis During Renal Ischemia-Reperfusion ÇÔ¿µ·Ï(Ãæ³²´ëÇб³º´¿ø) ÈÞ½Ä 06¿ù 14ÀÏ 10:00~10:30 Break () ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 10:30~10:50 Stem Cells as Therapy in AKI Xin-Min Chen(University of Sydney) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 10:50~11:10 Organelle Cross Talk on Kidney Cell Fate Reiko Inagi(The University of Tokyo Graduate School of Medicine) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 11:10~11:30 Kidney Organoids Uses and Limitations Yun Xia(Nanyang Technology University) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 11:30~11:50 G-protein Receptors as Targets in CKD Darren Kelly(The University of Melbourne) Åä·Ð 06¿ù 14ÀÏ Room 4 11:50~12:00 Q&A All Speaker() Åä·Ð 06¿ù 14ÀÏ Room 4 15:00~16:30 Oral Communications 6: Basic Research À¯ÅÂÇö, Carol Pollock(¼¼ºê¶õ½ºº´¿ø, North Shore Private Hospital) ÈÞ½Ä 06¿ù 14ÀÏ 16:30~17:00 Break () ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 17:00~17:20 Pathogenesis of Pediatric Nephrotic Syndrome Tomoko Horinouchi(Kobe University Graduate School of Medicine) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 17:20~17:40 Genetics of Congenital/Infantile Nephrotic Syndrome Ng Kar Hui(National University Hospital ) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 17:40~18:00 Difficult to Treat Nephrotic Syndrome Arvind Bagga(All India Institute of Medical Sciences) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 4 18:00~18:20 Recurrent Glomeruolonephritis after Transplant Stephen Marks(Great Ormond Street Hospital) Åä·Ð 06¿ù 14ÀÏ Room 4 18:20~18:30 Q&A All Speaker() ±³À°½Ã°£ 06¿ù 14ÀÏ Room 5 08:30~08:50 Dietary Risk Factors for CKD: Result from Prospective Cohort ÁÖ¿µ¼ö(¿ëÀμ¼ºê¶õ½ºº´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 5 08:50~09:10 Finding the Sweet Spot: The Role of Diet in Diabetic Kidney Disease Connie Rhee(University of California, Irvine) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 5 09:10~09:30 Should Plant Based Diet be the Preferred Dietary Approach to Ketoanalogue-supplemented Diet in CKD? KS Nayak(Virinchi Hospitals) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 5 09:30~09:50 Plant Based Diet and Mediterranean Style Diet Kelly Lambert(University of Wollongong) Åä·Ð 06¿ù 14ÀÏ Room 5 09:50~10:00 Q&A All Speaker() ÈÞ½Ä 06¿ù 14ÀÏ 10:00~10:30 Break () ±³À°½Ã°£ 06¿ù 14ÀÏ Room 5 10:30~10:50 Clinical Significance of Molecular Matching ¿ÀÀºÁö(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 5 10:50~11:10 Performance Characteristics of Cell Free DNA Vikas Dharnidharka(Washington University School of Medicine in St.Louis) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 5 11:10~11:30 Advances in Anti-humoral Therapy ¾çÀç¼®(¼¼ºê¶õ½ºº´¿ø) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 5 11:30~11:50 Cellular Therapies in Kidney Transplantation Stephen Alexander(Children) Åä·Ð 06¿ù 14ÀÏ Room 5 11:50~12:00 Q&A All Speaker() Åä·Ð 06¿ù 14ÀÏ Room 5 15:00~16:30 Oral Communications 7: Chronical Kidney Disease 1 Motoko Yanagita, ÇÑ»ó¿±(Kyoto University, ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø) ÈÞ½Ä 06¿ù 14ÀÏ 16:30~17:00 Break () ±³À°½Ã°£ 06¿ù 14ÀÏ Room 5 17:00~17:20 Role of Senescence of Aging Kidney Helen Healy(University of Queensland) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 5 17:20~17:40 How to Manage Sarcopenia in CKD Patients? Reshma Aziz Merchang(National University Health System) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 5 17:40~18:00 Frailty Renal Phenotype: Identify and Manage Those in Need Chia-Ter Chao(National Taiwan University Hosptial) ±³À°½Ã°£ 06¿ù 14ÀÏ Room 5 18:00~18:20 A Pragmatic Randomized Clinical Trial: Twice Weekly VS Thrice Weekly Incident Hemodialysis in Elderly Patients ÀÌÇØ°æ(¼øõÇâ´ëÇб³ ºÎ¼Ó ¼¿ïº´¿ø) Åä·Ð 06¿ù 14ÀÏ Room 5 18:20~18:30 Q&A All Speaker() ±³À°½Ã°£ 06¿ù 14ÀÏ Room 6 15:00~16:05 Satellite Symposium (IgA Nephropathy) Hong Zhang, Yusuke Suzuki(Peking University First Hospital, Juntendo University Faculty of Medicine) Åä·Ð 06¿ù 14ÀÏ Room 6 16:05~16:30 Q&A All Speaker() ±³À°½Ã°£ 06¿ù 14ÀÏ Auditorium 13:30~14:20 Plenary Lecture 2: How will Treatment for IgA Nephropathy Evolve over the Next 5 Years? Jonathan Barratt(Leicester General Hospital)
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|